Delivery Order SPE2DB25D3201-SPE2DB25FNVLT
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Dupixent 300 mg/2 mL syringes valued at $4,991.39. This non-set-aside, firm fixed-price delivery order is scheduled for completion by July 28, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The award represents a discrete purchase under AmerisourceBergen's existing contract vehicle with the DLA. AmerisourceBergen Drug Corp is a major...
- The Defense Logistics Agency awarded a $29,915.39 delivery order to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL syringes under a firm fixed price contract. The award was issued on August 11, 2025, with an ultimate completion date of August 12, 2025, and represents a non-set-aside competitive procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor for this medical supply delivery order. This delivery order operates as a...
- The Defense Logistics Agency awarded a $4,791.86 delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Dupixent 300 mg/2 ml syringes (2 ml volume). The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The pharmaceutical products will be delivered to the contractor's location in Conshohocken, Pennsylvania, with an ultimate completion date of July 23, 2025. This delivery order...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for Dupixent 300mg/2ml syringes valued at $44,390.30. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 20, 2025, with performance at the contractor's corporate office location in Conshohocken, Pennsylvania. The award does not utilize a set-aside designation and represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Dupixent 200 mg/1.14 mL syringes valued at $57,226.24. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 22, 2025, with performance of work taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting...
- The Defense Logistics Agency awarded a delivery order valued at $44,935.54 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml syringes on July 22, 2025, with an ultimate completion date of July 23, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a single-line procurement under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $45,274.14 to AmerisourceBergen Drug Corp for the supply of Dupixent (dupilumab) 300 mg/2 mL syringes on August 27, 2025, with a completion date of August 28, 2025. This contract utilizes a firm fixed-price delivery order structure with no set-aside designation, indicating competitive award through open procurement channels. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a $16,259.88 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml syringes, with an ultimate completion date of August 28, 2025. This competitively awarded contract, with no set-aside designation, is being performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under a larger contract vehicle that enables AmerisourceBergen to...
- The Defense Logistics Agency awarded a delivery order valued at $1,709.46 to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 ml syringes on July 29, 2025, with an ultimate completion date of July 30, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed price pricing and represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The product will be supplied from the vendor's location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,709.46 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml syringes on July 21, 2025. This firm fixed-price, non-set-aside delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. The contract was...
- SPE2DB25D3201Indefinite Delivery Contract
- SPE2DB25D3201-SPE2DB25FNVLTDelivery Order
The Defense Logistics Agency awarded a $47,704.56 delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Dupixent 300 mg/2 mL syringes. This is a firm fixed price, non-set-aside contract with an ultimate completion date of August 8, 2025, and represents a child order under AmerisourceBergen's larger contract vehicle with DLA. The pharmaceutical product will be delivered to AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's comprehensive Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical federal healthcare vendor, AmerisourceBergen supplies military and veteran healthcare systems with a broad range of pharmaceutical products and medical supplies through competitively awarded contracts. The Dupixent delivery supports DLA's medical supply chain operations, which serve the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems with specialty medications and biologics across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $47.7k | 8/7/25 |